Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study To Assess A Novel Form Of Cataract Treatment Using The Non-Invasive REVISYON Proof-Of-Concept Device

NCT04569318 is registered in ClinicalTrials.gov with Edinburgh Biosciences Ltd as lead sponsor.

NCT NCT04569318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04569318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study To Assess A Novel Form Of Cataract Treatment Using The Non-Invasive REVISYON Proof-Of-Concept Device
Lead sponsor
Edinburgh Biosciences Ltd
Phase
Not applicable
Overall status
Completed
Start date
October 19, 2020
Completion date
September 9, 2021
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cataract